Global Site Directed Mutagenesis System Market Research Report 2023

Publication ID:

PB510231975

Publication Date:

October 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Site Directed Mutagenesis is an in vitro artificial technique for creating mutation or alteration by insertions, deletions into any targeted DNA sequence. The site directed mutagenesis systems is technology PCR-based diagnostic technique. The genetic engineering using site directed mutagenesis can be used to produce insulin, modified vaccines and other drugs.
The global Site Directed Mutagenesis System market is projected to reach US$ 685.5 million in 2029, increasing from US$ 460 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2029.
Global Site Directed Mutagenesis System Market
The global site-directed mutagenesis system market refers to the market for systems and tools used in the field of molecular biology for the creation of specific mutations in DNA sequences. Site-directed mutagenesis is a technique used to introduce specific changes in the genetic code of an organism, allowing researchers to study the effects of these mutations on protein function, gene expression, and disease development.
The site-directed mutagenesis system market includes a variety of products and technologies, such as PCR-based mutagenesis kits, synthetic DNA oligonucleotides, cloning vectors, and mutagenesis enzymes. These products enable researchers to introduce desired mutations into the DNA sequence of interest and study the resulting effects on biological processes.
The market for site-directed mutagenesis systems is primarily driven by the increasing demand for genetic engineering and gene editing technologies in various research disciplines, including pharmaceuticals, biotechnology, agriculture, and academic research. The ability to precisely manipulate and study genes is crucial for understanding disease mechanisms, developing new therapeutics, and improving crop traits.
Geographically, North America holds a significant share in the global site-directed mutagenesis system market. The region has a strong presence of major biotechnology and pharmaceutical companies, as well as leading research institutions, which contribute to the demand for advanced genetic engineering tools. Europe and Asia Pacific also have a considerable market presence, driven by research and development activities and growing investments in life sciences.
Key players in the global site-directed mutagenesis system market include Thermo Fisher Scientific, Agilent Technologies Inc., Merck KGaA, Qiagen N.V., New England Biolabs, Inc., GenScript Biotech Corporation, and OriGene Technologies, Inc., among others. These companies are actively involved in product development, collaborations, and strategic acquisitions to strengthen their market position and expand their product portfolios.
In summary, the global site-directed mutagenesis system market is driven by the increasing demand for genetic engineering tools in various research disciplines. The market is expected to continue growing as advancements in gene editing technologies and increasing research investments fuel innovation in the field. With the potential for broad applications in healthcare, agriculture, and other industries, the site-directed mutagenesis system market presents significant opportunities for manufacturers and researchers alike.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Site Directed Mutagenesis System market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Thermo Fisher Scientific.
Takara Bio Inc.
Genomax Technologies Pvt. Ltd.
Agilent Technologies Inc.
Transgen Biotech Co. Ltd.
EZ Bioscience
GenSCript.
Merck KGaA
Qiagen N.V
New England Biolabs, Inc
OriGene Technologies, Inc
Segment by Type
Single Site Directed Mutagenesis
Multiple Site Directed Mutagenesis
Segment by Application
Cancer
Diabetes
Cystic Fibrosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Site Directed Mutagenesis System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Site Directed Mutagenesis System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single Site Directed Mutagenesis
1.2.3 Multiple Site Directed Mutagenesis
1.3 Market by Application
1.3.1 Global Site Directed Mutagenesis System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Cystic Fibrosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Site Directed Mutagenesis System Market Perspective (2018-2029)
2.2 Site Directed Mutagenesis System Growth Trends by Region
2.2.1 Global Site Directed Mutagenesis System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Site Directed Mutagenesis System Historic Market Size by Region (2018-2023)
2.2.3 Site Directed Mutagenesis System Forecasted Market Size by Region (2024-2029)
2.3 Site Directed Mutagenesis System Market Dynamics
2.3.1 Site Directed Mutagenesis System Industry Trends
2.3.2 Site Directed Mutagenesis System Market Drivers
2.3.3 Site Directed Mutagenesis System Market Challenges
2.3.4 Site Directed Mutagenesis System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Site Directed Mutagenesis System Players by Revenue
3.1.1 Global Top Site Directed Mutagenesis System Players by Revenue (2018-2023)
3.1.2 Global Site Directed Mutagenesis System Revenue Market Share by Players (2018-2023)
3.2 Global Site Directed Mutagenesis System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Site Directed Mutagenesis System Revenue
3.4 Global Site Directed Mutagenesis System Market Concentration Ratio
3.4.1 Global Site Directed Mutagenesis System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Site Directed Mutagenesis System Revenue in 2022
3.5 Site Directed Mutagenesis System Key Players Head office and Area Served
3.6 Key Players Site Directed Mutagenesis System Product Solution and Service
3.7 Date of Enter into Site Directed Mutagenesis System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Site Directed Mutagenesis System Breakdown Data by Type
4.1 Global Site Directed Mutagenesis System Historic Market Size by Type (2018-2023)
4.2 Global Site Directed Mutagenesis System Forecasted Market Size by Type (2024-2029)
5 Site Directed Mutagenesis System Breakdown Data by Application
5.1 Global Site Directed Mutagenesis System Historic Market Size by Application (2018-2023)
5.2 Global Site Directed Mutagenesis System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Site Directed Mutagenesis System Market Size (2018-2029)
6.2 North America Site Directed Mutagenesis System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Site Directed Mutagenesis System Market Size by Country (2018-2023)
6.4 North America Site Directed Mutagenesis System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Site Directed Mutagenesis System Market Size (2018-2029)
7.2 Europe Site Directed Mutagenesis System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Site Directed Mutagenesis System Market Size by Country (2018-2023)
7.4 Europe Site Directed Mutagenesis System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Site Directed Mutagenesis System Market Size (2018-2029)
8.2 Asia-Pacific Site Directed Mutagenesis System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Site Directed Mutagenesis System Market Size by Region (2018-2023)
8.4 Asia-Pacific Site Directed Mutagenesis System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Site Directed Mutagenesis System Market Size (2018-2029)
9.2 Latin America Site Directed Mutagenesis System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Site Directed Mutagenesis System Market Size by Country (2018-2023)
9.4 Latin America Site Directed Mutagenesis System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Site Directed Mutagenesis System Market Size (2018-2029)
10.2 Middle East & Africa Site Directed Mutagenesis System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Site Directed Mutagenesis System Market Size by Country (2018-2023)
10.4 Middle East & Africa Site Directed Mutagenesis System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific.
11.1.1 Thermo Fisher Scientific. Company Detail
11.1.2 Thermo Fisher Scientific. Business Overview
11.1.3 Thermo Fisher Scientific. Site Directed Mutagenesis System Introduction
11.1.4 Thermo Fisher Scientific. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.1.5 Thermo Fisher Scientific. Recent Development
11.2 Takara Bio Inc.
11.2.1 Takara Bio Inc. Company Detail
11.2.2 Takara Bio Inc. Business Overview
11.2.3 Takara Bio Inc. Site Directed Mutagenesis System Introduction
11.2.4 Takara Bio Inc. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.2.5 Takara Bio Inc. Recent Development
11.3 Genomax Technologies Pvt. Ltd.
11.3.1 Genomax Technologies Pvt. Ltd. Company Detail
11.3.2 Genomax Technologies Pvt. Ltd. Business Overview
11.3.3 Genomax Technologies Pvt. Ltd. Site Directed Mutagenesis System Introduction
11.3.4 Genomax Technologies Pvt. Ltd. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.3.5 Genomax Technologies Pvt. Ltd. Recent Development
11.4 Agilent Technologies Inc.
11.4.1 Agilent Technologies Inc. Company Detail
11.4.2 Agilent Technologies Inc. Business Overview
11.4.3 Agilent Technologies Inc. Site Directed Mutagenesis System Introduction
11.4.4 Agilent Technologies Inc. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.4.5 Agilent Technologies Inc. Recent Development
11.5 Transgen Biotech Co. Ltd.
11.5.1 Transgen Biotech Co. Ltd. Company Detail
11.5.2 Transgen Biotech Co. Ltd. Business Overview
11.5.3 Transgen Biotech Co. Ltd. Site Directed Mutagenesis System Introduction
11.5.4 Transgen Biotech Co. Ltd. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.5.5 Transgen Biotech Co. Ltd. Recent Development
11.6 EZ Bioscience
11.6.1 EZ Bioscience Company Detail
11.6.2 EZ Bioscience Business Overview
11.6.3 EZ Bioscience Site Directed Mutagenesis System Introduction
11.6.4 EZ Bioscience Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.6.5 EZ Bioscience Recent Development
11.7 GenSCript.
11.7.1 GenSCript. Company Detail
11.7.2 GenSCript. Business Overview
11.7.3 GenSCript. Site Directed Mutagenesis System Introduction
11.7.4 GenSCript. Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.7.5 GenSCript. Recent Development
11.8 Merck KGaA
11.8.1 Merck KGaA Company Detail
11.8.2 Merck KGaA Business Overview
11.8.3 Merck KGaA Site Directed Mutagenesis System Introduction
11.8.4 Merck KGaA Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.8.5 Merck KGaA Recent Development
11.9 Qiagen N.V
11.9.1 Qiagen N.V Company Detail
11.9.2 Qiagen N.V Business Overview
11.9.3 Qiagen N.V Site Directed Mutagenesis System Introduction
11.9.4 Qiagen N.V Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.9.5 Qiagen N.V Recent Development
11.10 New England Biolabs, Inc
11.10.1 New England Biolabs, Inc Company Detail
11.10.2 New England Biolabs, Inc Business Overview
11.10.3 New England Biolabs, Inc Site Directed Mutagenesis System Introduction
11.10.4 New England Biolabs, Inc Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.10.5 New England Biolabs, Inc Recent Development
11.11 OriGene Technologies, Inc
11.11.1 OriGene Technologies, Inc Company Detail
11.11.2 OriGene Technologies, Inc Business Overview
11.11.3 OriGene Technologies, Inc Site Directed Mutagenesis System Introduction
11.11.4 OriGene Technologies, Inc Revenue in Site Directed Mutagenesis System Business (2018-2023)
11.11.5 OriGene Technologies, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific.
Takara Bio Inc.
Genomax Technologies Pvt. Ltd.
Agilent Technologies Inc.
Transgen Biotech Co. Ltd.
EZ Bioscience
GenSCript.
Merck KGaA
Qiagen N.V
New England Biolabs, Inc
OriGene Technologies, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂